Showing results (481-490 of 716) with videos related to
Sort By:
Pageof 72
Nature Communications|February 19, 2021
Fecal microbiota transplantation in HIV: A pilot placebo-controlled studySergio Serrano-Villar, Alba Talavera-Rodríguez, María José Gosalbes, et al.International Journal of Molecular Sciences|September 13, 2025
Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir SizeErick De La Torre Tarazona, Elisa Moraga, María Fons-Contreras, et al.The Journal of Infectious Diseases|May 26, 2021
Cellular Activation, Differentiation, and Proliferation Influence the Dynamics of Genetically Intact Proviruses Over TimeBethany A Horsburgh, Bonnie Hiener, Katie Fisher, et al.Science Translational Medicine|July 12, 2013
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolismIvan Vujkovic-Cvijin, Richard M Dunham, Shoko Iwai, et al.Retrovirology|October 18, 2013
Expression profile of host restriction factors in HIV-1 elite controllersMohamed Abdel-Mohsen, Rui André Saraiva Raposo, Xutao Deng, et al.JCI Insight|April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 responseJames J Knox, Marcus Buggert, Lela Kardava, et al.JAMA|September 28, 2006
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infectionBenigno Rodríguez, Ajay K Sethi, Vinay K Cheruvu, et al.The Lancet. HIV|November 29, 2015
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation studyJulian H Elliott, James H McMahon, Christina C Chang, et al.Journal of Virology|January 23, 2015
Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progressionKiera L Clayton, Matthew B Douglas-Vail, A K M Nur-ur Rahman, et al.Immunity|November 29, 2024
Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapyMilica Moskovljevic, Filippo Dragoni, Nathan L Board, et al.Pageof 72